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Background/aim: Chronic Obstructive Pulmonary Disease (COPD) is one of the most common causes of death worldwide. Therefore,
optimizing medical therapy in the comprehensive management of the disease, as well as including pulmonary rehabilitation (PR) in the
treatment, is essential. The goal of our study was to determine the impact of PR on the survival of COPD patients.
Materials and methods: Between 2007–2015, 509 COPD patients who completed the PR constituted the PR group, while 167 patients
who applied but could not complete it after the initial evaluations formed the control group. In the PR group, dyspnea perception,
exercise capacity, muscle strength, body composition, quality of life, psychosocial status, and i-BODE scores were assessed at the
beginning and end of the program, whereas in the control group, these assessments could only be conducted at the beginning. Also,
after PR, our PR participants have prescribed a home exercise program, and they were recalled to the hospital at the 3rd, 6th, 12th, 18th,
and 24th months for follow-up visits.
Results: A statistically significant improvement was found in almost all the data (except FEV1/FVC, BORG after exercise, and FFMI)
after PR. There was a statistically significant difference in 5-year survival in favor of the PR group (p = 0.006), and in PR patients who
accompanied the home exercise program vs. those who did not (p = 0.000). Also the gains in MRC (p = 0.003; OR: 2.20; CI: 1.319–
3.682), MEP (p = 0.041; OR: 1.02; CI: 1.001–1.035), and i-BODE (p = 0.006; OR: 0.914; CI: 0.857–0.974) increased the survival.
Conclusion: Apart from incorporating PR into treatment in the comprehensive management of COPD, we demonstrated that
maintaining a home exercise program for at least two years following PR increased 5-year survival significantly.
Key words: Chronic obstructive pulmonary disease, pulmonary rehabilitation, home exercise program, maintenance, 5-year survival

1. Introduction
After ischemic heart disease and stroke, Chronic
Obstructive Pulmonary Disease (COPD) is one of the
leading causes of death, which is also related to high
morbidity and disability [1]. Although low physical
activity is shown as the most important predictor of
mortality in COPD [2]; frequency of acute exacerbations
[3], weight loss (especially low fat free mass indexFFMI) [4], comorbidities (especially coronary artery
diseases) [5], and i-BODE index [6] are the other
predictors of mortality in COPD. So while managing the
symptoms and exacerbations of the disease, an important
addition to the pharmacological treatment is to provide
nonpharmacological approaches including pulmonary
rehabilitation (PR) and self-management education.
In this retrospective controlled study, we aimed to
compare the 5-year survival results of COPD patients who
completed an 8-week comprehensive, multidisciplinary,
outpatient, and directly supervised PR program with those

who did not, as well as the 5-year survival of the patients
who continued a home exercise program for 2 years after
the end of PR and came to their scheduled controls,
also the factors affecting survival, and finally share our
outcomes as it is one of the few controlled studies with a
large number of patients.
2. Materials and methods
2.1. Study population
Between 2007 and 2015, 839 COPD patients were
referred to our PR center, however, 163 were considered
inappropriate for PR due to conditions such as uncontrolled
heart failure, hypertension, cancer, unstable angina
pectoris, severe pulmonary embolism or thrombosis, or
major neurological diseases. So 676 patients were eligible
for the PR program and were included in the study. While
509 patients who completed the program formed the
PR group and the remaining 167 patients who did not
complete the program for various reasons (active work-life,
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transportation, or compatibility problems) were separated
as the control group. One hundred and thirty-two patients
who completed PR maintained the home exercise program
prescribed at the end of PR and attended their regularly
scheduled sessions for two years, while the remaining 377
patients did not continue their home exercises and did not
attend their scheduled sessions (Figure 1). The electronic
medical data system at our hospital, as well as the Ministry
of Health information system integrated into it, were
utilized to screen the 5-year mortality in both the PR and
control groups.
2.2. Outcome parameters
A spirometry was used to measure pulmonary function [7].
Respiratory muscle strength was assessed using a MicroRPM (respiratory pressure meter). To examine peripheral
muscle strength, hand grip test with hand dynamometer
was applied. Incremental shuttle walking test (ISWT)
and endurance shuttle walking test (ESWT) were used to
assess exercise capacity [8,9]. The St. George’s Respiratory
Questionnaire (SGRQ) was used to measure health1
Figure 1: Patient distribution chart.
2
3

related quality of life (HRQL) [10]. The medical research
council (MRC) scale was used to measure dyspnea [11].
Body compositions were determined by the bioelectrical
impedance method using TANITA (TBF-300A Total Body
Composition Analyzer, Tokyo, Japan). Psychological state
was determined using Hospital Anxiety and Depression
(HAD) scores [12]. Also, i-BODE values were calculated
using the body mass index (BMI), forced expiratory
volume in one s (FEV1), MRC scale, and ISWT. According
to their i-BODE values, patients were split into quartiles,
with cut-offs of 0 to 2 points in the first quartile (Q1), 3
to 4 points in the second quartile (Q2), 5 to 6 points in
the third quartile (Q3), and 7 to 10 points in the fourth
quartile (Q4) [6]. The survival status of all patients was
determined by scanning the online database records of the
Ministry of Health information system retrospectively.
The primary endpoint of our study was to investigate
the effect of 8-weeks of multidisciplinary, comprehensive,
outpatient, directly supervised PR, as well as1 the effect of
maintenance of a home exercise program after PR and
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377 patients did not continue the
home exercise program after
finishing the program and did not
attend the planned PR follow-up
at 24 months.
Figure 1. Patient distribution chart.

After completing the program, 132
patients maintained with the home
exercise program and attended for
the planned PR follow-up at 24
months.
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adhering to a 2-year scheduled follow-up program on
5-year survival in patients with COPD. Our secondary
endpoint was to determine which PR gain was associated
with the 5-year survival.
2.3. Pulmonary rehabilitation
After the evaluation of the patients, an individualized
8-week hospital-based comprehensive PR program for
two half days each week was designed. Endurance and
resistance training were included in the program. Leg
extensions with free weights were performed 2 days a week.
Patients with low maximal inspiratory pressure (MIP)
values were

given inspiratory muscle training (IMT), with
an inspiratory load of 30%–50% of MIP. The patients’
heart rates, blood pressure results, and oxygen saturations
were monitored during the sessions. If necessary, oxygen
supplementation was administered to keep the oxygen
level over 90%.
The PR group have also been prescribed a home
exercise program, and scheduled follow-up appointments
were created at the 3rd, 6th, 12th, 18th, and 24th months
to check compliance.
2.4. Ethical consideration
We applied to the “Medical Specialization Education
Board” in our institution and received approval for our
study on 15 October 2020 with decision number 697-7.
2.5. Statistical analysis
The Statistical Package for the Social Sciences version
18.0 (SSPS, Chicago, IL, USA) software system was used
to conduct statistical analyses. Categorical variables
were represented with numbers and percentages (%).
The Shapiro-Wilk test was performed to determine
the normality of the distribution of the variables. The
Chi-square test was employed to examine connections
between categorical variables. The McNemar test was
used to evaluate categorically dependent data, whereas
the Man Whitney U test was used to analyze independent
data. Relationships between variables with nonnormal
distributions were investigated using Spearman
correlation analysis. Relationships between variables were
investigated using regression analysis. The 5-year survival
was evaluated with the chi-square test. For statistical
significance, the p-value was adjusted to be less than 0.05
(p < 0.005).
According to the G-power analysis, the study should
have a minimum of 132 controls and 440 study patients,
with a confidence interval of 0.90, a level of significance of
0.05, and an effect size of 0.33.
3. Results
The mean ages of the PR and control group were 63.95, and
64.22, respectively. Ex-smokers comprised the majority
of patients in both groups. All parameters were found to

be similar between the two groups except SGRQ, HAD
scores, and the total 5-year survival rates. As the primary
endpoint of our study, the 5-year survival was significantly
higher in the PR group compared to the control group (p
= 0.006). Detailed demographic data of both groups are
given in Table 1.
When we divided the patients according to i-BODE
quartiles, there was no difference between the 5-year
survival rates of the patients in both groups (p = 0.084 for
Q1, p = 0.125 for Q2, p = 0.399 for Q3, and p = 0.062 for
Q4, respectively).
After
PR
program,
statistically
significant
improvements were detected in nearly all of the patients’
data. The detailed values before and after PR are given in
Table 2.
When we consider the effects of PR gains on 5-year
survival, only the improvements in MRC, maximal
expiratory pressure (MEP), and i-BODE have a statistically
significant influence on the survival (p = 0.003, p = 0.007
and p = 0.007, respectively). In the regression analysis
of PR group, it was found that gains in MRC (p = 0.003;
OR: 2.20; CI: 1.319–3.682), MEP (p = 0.041; OR: 1.02;
CI: 1.001–1.035), and i-BODE (p = 0.006; OR: 0.914; CI:
0.857–0.974) increased the survival.
Only 132 of the 509 PR patients maintained the home
exercise program after finishing the program and came to
the hospital for the scheduled PR follow-up at the 24th
month, whereas the remaining 377 patients did not. As
shown in Table 3 and Figure 2, patients who continued
their home exercise programs after PR and participated in
PR control after 24 months had a statistically significant
positive effect on 5-year survival (p = 0.000). Furthermore,
these patients’ BMI, FFMI, SGRQ, and BORG gains
remained statistically significant at month 24.
4. Discussion
The effect of a multidisciplinary, comprehensive, directly
supervised, hospital-based, out-patient PR program on
COPD patients’ 5-year survival rates was evaluated in this
long-term follow-up study, and when the groups were
compared, the PR group had a significantly higher 5-year
survival rate. Furthermore, we discovered that patients
who continued the home exercise program following PR
and attended scheduled hospital follow-ups for up to two
years had a significantly better 5-year survival rate than
those who did not. We also concluded that gains in MRC,
MEP, and i-BODE improve survival.
Dyspnea, presence of comorbidities, BMI, predicted
FEV1%, exercise capacity, exacerbations, some biomarkers,
inspiratory capacity, and anemia have all been linked to
mortality in COPD patients [13].
PR, which is a cost-effective strategy (evidence level
2C), improves exercise tolerance, symptoms, and HRQL
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Table 1. Demographic data of both PR and control groups.
PR group

Control group

p

Age (years)

63.95 ± 8.60

64.22 ± 9.38

0.757

Sex (m/f) n (%)

446(87.6%)/63(12.4%)

148(88.6%)/9(11.4%)

0.731

Smoking (p/year)

50.11 ± 30.99

50.11 ± 33.24

0.940

LTOT presence n (%)

237 (49.1%)

78 (47.3%)

0.691

FEV1 predicted %

39.18 ± 18.04

38.80 ± 19.81

0.388

FVC predicted %

56.52 ± 18.80

54.36 ± 18.56

0.164

FEV1/FVC

54.80 ± 14.40

54.47 ± 15.52

0.442

MRC score

3.31 ± 0.92

3.41 ± 0.96

0.311

BORG at rest

0.57 ± 0.65

0.56 ± 0.71

0.296

BORG after exercise

3.45 ± 1.10

3.61 ± 1.43

0.162

ISWT (m)

213.72 ± 120.65

214.14 ± 127.43

0.729

ESWT (min.)

7.50 ± 6.88

7.40 ± 6.96

0.757

MIP (cmH2O)

59.88 ± 20.83

60.48 ± 22.26

0.805

MEP (cmH2O)

81.90 ± 39.13

86.77 ± 42.29

0.407

Handgrip (HG) test-R

30.33 ± 8.11

29.57 ± 8.12

0.096

Handgrip (HG) test-L

29.49 ± 7.93

28.45 ± 8.78

0.182

Deltoid strength-R

3.95 ± 0.82

3.81 ± 0.79

0.097

Deltoid strength-L

3.88 ± 0.81

3.77 ± 0.73

0.086

Quadriceps strength-R

4.27 ± 0.73

4.19 ± 0.75

0.299

Quadriceps strength-L

4.20 ± 0.72

4.05 ± 0.72

0.055

BMI (kg/m2)

25.06 ± 6.15

24.87 ± 6.95

0.463

FFMI (kg/m2)

18.83 ± 2.65

18.67 ± 2.86

0.587

SGRQ total score

65.65 ± 17.26

70.54 ± 17.74

0.001

HAD-Anxiety scores

9.50 ± 2.34

10.30 ± 2.07

0.000

HAD-Depression scores

9.43 ± 2.40

10.16 ± 1.94

0.000

i-BODE

4.39 ± 2.15

4.28 ± 2.15

0.727

Patients living 5 years n (%)

305 (60%)

80 (47.9%)

0.006

Data are presented as mean ± SD or n (%).
BMI: Body mass index; ESWT: Endurance shuttle walking test; FEV1: Forced expiratory volume in 1 s; FFMI: Fat-free mass index; FVC:
Forced vital capacity; HAD: Hospital anxiety depression score; ISWT: Incremental shuttle walking test; L: Left; LTOT: Long term oxygen
treatment; m/f: Male/female; MEP: Maximal expiratory pressure; min: Minute; MIP: Maximal inspiratory pressure; MRC: Medical
research council; n: Number; p/year: Packet/year; R: Right; SGRQ: St George’s Respiratory Questionnaire.

in COPD patients (evidence level 1A), as well as reducing
hospital stays and healthcare costs (evidence level 2B) [14].
In fact, in the study of Puhan M. et al. [15] pulmonary
rehabilitation was shown to be a highly effective and safe
intervention to reduce hospitalizations and mortality and
improve health-related quality of life in COPD patients
even after exacerbation. It is also effective in facilitating
smoking cessation, optimizing pharmacotherapy,
improving body composition, promoting mental health,
managing acute dyspnea, and detecting and managing
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acute exacerbations [16]. COPD patients have limited
physical activity, which is cited as one of the causes of
hospital admissions and mortality, due to shortness of
breath, muscle weakness, and/or respiratory failure [17].
All demographic data and baseline parameters of our
2 groups were found to be similar except for the quality of
life, and psychosocial status which may be related to the
inability of the control group to adapt and complete the PR.
In the PR group, statistically significant improvements were
found in pulmonary function tests, dyspnea perceptions,
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Table 2. Outcome measures before and after the PR program.
Parameters (n = 509)

Before PR

After PR

P-value

FEV1 predicted %

39.18 ± 18.04

40.88 ± 19.25

0.000

FVC predicted %

56.51 ± 18.80

58.46 ± 19.07

0.001

FEV1/FVC

54.80 ± 14.40

54.86 ± 14.37

0.917

MRC score

3.31 ± 0.92

2.57 ± 0.80

0.000

BORG at rest

0.57 ± 0.65

0.35 ± 0.50

0.000

BORG after exercise

3.47 ± 1.10

3.40 ± 1.11

0.195

ISWT (m)

213.72 ± 120.65

266.00 ± 125.21

0.000

ESWT (min)

7.50 ± 6.88

12.97 ± 7.53

0.000

MIP(cmH2O)

59.91 ± 20.87

66.02 ± 23.13

0.000

MEP (cmH2O)

81.90 ± 39.12

91.26 ± 43.54

0.000

Handgrip test-R

30.33 ± 8.11

32.51 ± 8.24

0.000

Handgrip test-L

29.49 ± 7.93

31.75 ± 8.17

0.000

Deltoid muscle strength-R

3.95 ± 0.82

4.27 ± 0.77

0.000

Deltoid muscle strength-L

3.88 ± 0.80

4.15 ± 0.79

0.000

Quadriceps muscle strength-R

4.27 ± 0.72

4.60 ± 0.60

0.000

Quadriceps muscle strength-L

4.20 ± 0.72

4.53 ± 0.63

0.000

BMI (kg/m2)

25.06 ± 6.15

25.33 ± 5.97

0.000

FFMI (kg/m2)

18.83 ± 2.64

18.86 ± 2.49

0.488

SGRQ Score

65.60 ± 17.26

35.12 ± 14.99

0.000

HAD-Anxiety

9.50 ± 2.34

6.57 ± 2.55

0.000

HAD-Depression

9.43 ± 2.40

6.68 ± 2.91

0.000

i-BODE

4.64 ± 2.13

3.42 ± 1.95

0.000

Data are presented as mean ± SD or n (%).
BMI: Body mass index; ESWT: Endurance shuttle walking test; FEV1: Forced expiratory volume in 1 s; FFMI: Fat-free mass index;
FVC: Forced vital capacity; HAD: Hospital anxiety depression score; ISWT: Incremental shuttle walking test; L: Left; MEP: Maximal
expiratory pressure; min: Minute; MIP: Maximal inspiratory pressure; MRC: Medical research council; n: Number; p/year: Packet/year;
R: Right; SGRQ: St George’s Respiratory Questionnaire.
Table 3. Relationship between 5-year survival in PR group with and without 24-month scheduled follow-up after the program.
PR group patients

Patients with follow-up for 24 months n (%) Patients without follow-up for 24 months n (%) P-value

Survivors

116 (87.7%)

189 (50.1%)

0.000

Nonsurvivors

16 (11.9%)

188 (49.9%)

0.000

n: Number; PR: Pulmonary rehabilitation

exercise capacities, respiratory and peripheral muscle
strength, body composition, quality of life, psychosocial
status, and i-BODE index after PR. Also, the 5-year
survival rate of these patients was significantly higher than
the control group and we concluded that the benefit of PR
in terms of survival was similar to the literature [2,18]. In
the publications, respiratory muscle dysfunction has also

been identified as a possible predictor of higher use of
health resources and mortality in COPD. Our study also
showed that the MRC and MEP gains of the patients with
5-year survival were statistically higher than those who
did not survive, so the contribution of PR to dyspnea and
respiratory muscle strength is associated with survival, and
even more objectively, it was found that a 1-unit increase in
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Figure 2. The percentage of 5-year survival by years of patients who maintained the
home PR program and attended to their 24-month follow-up versus those who did
not maintain the home PR program and did not come for their 24-month follow-up.

MRC increased the survival 2.20 times and 1-unit increase
in MEP levels increased the survival 1.02 times. According
to Houchen-Wolloff L.’s study, better MRC levels, higher
baseline ISWT and BMI values, younger age at baseline,
and no need for oxygen therapy were associated with
higher survival rates [2]. Similar to our study, Decramer
M. et al. [19] found that the number of hospital admissions,
hospitalization days, and out-patient visits were all related
to respiratory and peripheral muscle strength; especially
the association was statistically significant for maximal
expiratory pressure (PE max). Also, Vilaro J. et al. [20]
reported that expiratory muscle weakness is a risk factor for
readmission to the hospital because of acute exacerbations
which are related to higher mortality rates.
Body composition, airway obstruction, dyspnea
perception, and exercise capacity make up the i-BODE
index, which is one of the indicators of mortality in COPD.
The i-BODE index was found to be an independent and
substantial predictor of death in research involving 633
patients who received PR, and each quartile increase in
severity in the i-BODE score was significantly related to
higher mortality [6]. From another research, the i-BODE
index was found to be more directly correlated with
survival than the individual components in 674 patients
who had 7-week PR [21]. Also, the i-BODE score was
significantly lower among the survivors in our study when
the data of patients who survived and did not survive
for 5 years were compared. However, when our patients
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were divided into quartiles based on their i-BODE values,
there was no statistically significant relationship between
percentiles and 5-year survival for both groups. This result
appeared to be due to the fact that the number of patients
in these two groups was insufficient for statistical analysis,
and the PR and control groups’ initial i-BODE values were
similar at baseline.
Because low levels of physical activity are linked to
mortality, there is an increasing demand for supporting a
long-term lifestyle change that includes more activity and
less sedentary behavior. According to a recent systematic
review and meta-analysis, post-PR patients were followed
with supervised maintenance therapy for up to 36
months, and it was discovered that continuous supervised
maintenance exercise reduced the number of respiratory
hospitalizations and deaths when compared to standard
care [22]. Güell MR. et al. [23] revealed that the gain in
BODE index and 6MWT continue in the 2-year follow-up
after PR in COPD. According to Blervaque L. et al’s study,
after a pragmatic maintenance PR program, 144 patients
with COPD were followed annually for 5 years and
demonstrated significant PR gains in 6MWT and HRQL
at 4 years and MRC at 5 years [24]. Furthermore, they
discovered that PR patients had a higher 5-year survival
rate than the others.
Although there are various studies on the long-term
effectiveness of PR in COPD, there are few studies on
the benefit of continuing a home exercise program after
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PR on survival other than the existing gains. In a metaanalysis of the long-term effects of PR with low-frequency
maintenance on exercise capacity and health-related
quality of life in COPD patients, it was discovered that PR
with maintenance programs appears to be more effective
than PR without maintenance programs for preserving
exercise capacity in the long-term follow-up, but
maintenance was not effective on health-related quality
of life [25]. The recurrent prescription of home exercise
training at 6-month intervals may have contributed to the
high 5-year survival rate, according to a study conducted
with 33 COPD patients from Turkey [26]. When we
compared the PR group patients who continued the home
exercise program after completing the PR and came for
the scheduled controls, including the 2nd year, to those
who did not, we discovered that the 5-year survival in the
group who continued the PR program at home and came
to the control was better than the other group, and that
the gain in BMI, FFMI, SGRQ, and BORG after exercise
continued at the 24th month. This demonstrated that
patients who finished a directly supervised PR program
should continue to exercise at home to preserve their gains
and have a higher survival rate.
Our study’s strengths include the fact that it was a
randomized controlled trial with a large number of patients,
that the program was implemented by a multidisciplinary
team in an experienced PR center, and that the patients were

followed for an extended period of time with a structured
follow-up program. The most significant restriction of
our research is that the majority of our data on patients’
compliance with the home maintenance program mainly
based on the patient’s statement.
5. Conclusion
In this study, we demonstrated that not only completing
PR but also continuing a home exercise program and
confirming this with directly supervised hospital controls
for up to 2 years improves 5-year survival in COPD
patients.
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